NeuroPace, Inc.
General ticker "NPCE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $347.8M (TTM average)
NeuroPace, Inc. follows the US Stock Market performance with the rate: 5.3%.
Estimated limits based on current volatility of 3.9%: low 16.03$, high 17.09$
Factors to consider:
- Total employees count: 184 (+7.6%) as of 2024
- Countries other than US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Regulatory and compliance, Cybersecurity threats, Labor/talent shortage/retention, Manufacturing challenges and quality control
- Current price 31.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.57$, 12.89$]
- 2025-12-31 to 2026-12-31 estimated range: [4.76$, 11.23$]
Financial Metrics affecting the NPCE estimates:
- Negative: with PPE of -11.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.55 <= 0.33
- Positive: Inventory ratio change, % of 0.43 <= 0.84
- Positive: Interest expense per share per price, % of 2.72 <= 3.41
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term NPCE quotes
Long-term NPCE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $45.52MM | $65.42MM | $79.91MM |
| Operating Expenses | $86.31MM | $92.59MM | $101.58MM |
| Operating Income | $-40.79MM | $-27.17MM | $-21.67MM |
| Non-Operating Income | $-6.29MM | $-5.78MM | $-5.47MM |
| Interest Expense | $7.53MM | $8.52MM | $8.80MM |
| R&D Expense | $21.95MM | $20.78MM | $23.65MM |
| Income(Loss) | $-47.08MM | $-32.96MM | $-27.14MM |
| Profit(Loss)* | $-47.08MM | $-32.96MM | $-27.14MM |
| Stockholders Equity | $34.78MM | $20.65MM | $8.01MM |
| Inventory | $9.71MM | $11.21MM | $13.38MM |
| Assets | $114.11MM | $107.65MM | $94.65MM |
| Operating Cash Flow | $-36.87MM | $-19.70MM | $-17.95MM |
| Capital expenditure | $0.60MM | $0.17MM | $0.31MM |
| Investing Cash Flow | $23.80MM | $23.03MM | $8.99MM |
| Financing Cash Flow | $0.49MM | $8.13MM | $4.33MM |
| Earnings Per Share** | $-1.91 | $-1.27 | $-0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.